Back
Pluri, Inc. 10K Form
Sell
4
PLUR
Pluri, Inc.
Last Price:
$3.52
Seasonality Move:
21.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PLUR News And Ratings
See the #1 stock for the next 7 days that we like better than PLUR
PLUR Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3M |
|---|---|
| Cash Flow: | $-5.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.39 |
| Price / Book: | 321.11 |
Profitability
| EPS (TTM): | -3.08160 |
|---|---|
| Net Income (TTM): | $-23.3M |
| Gross Margin: | $338K |
| Return on Equity: | -5662.45% |
| Return on Assets: | -66.3% |
Pluri, Inc. Earnings Forecast
Key Pluri, Inc. Financial Ratios
-
The Gross Profit Margin over the past 23 years for PLUR is 25.30%.
-
The Selling, General & Administrative Expenses for PLUR have been equal to 746.93% of Gross Profit Margin.
-
The Research & Development expenses have been 961.90% of Revenue.
-
The Net Earning history of PLUR is -1,740.27% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 16 years.
Pluri, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PLUR |
| Website: | pluri-biotech.com |
Debt
| Debt-to-Equity Ratio: | -3.01 |
|---|---|
| Current Ratio: | 0.53 |
| Quick Ratio: | 0.49 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PLUR Technical Analysis vs Fundamental Analysis
Sell
4
Pluri, Inc. (PLUR)
is a Sell
Is Pluri, Inc. a Buy or a Sell?
-
Pluri, Inc. stock is rated a SellThe current Pluri, Inc. [PLUR] share price is $3.26. The Score for PLUR is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.